DK2424523T3 - Sublingual sprayformulering med dihydroartemisinin - Google Patents

Sublingual sprayformulering med dihydroartemisinin

Info

Publication number
DK2424523T3
DK2424523T3 DK10715337.1T DK10715337T DK2424523T3 DK 2424523 T3 DK2424523 T3 DK 2424523T3 DK 10715337 T DK10715337 T DK 10715337T DK 2424523 T3 DK2424523 T3 DK 2424523T3
Authority
DK
Denmark
Prior art keywords
dihydroartemisinin
spray formulation
sublingual spray
sublingual
formulation
Prior art date
Application number
DK10715337.1T
Other languages
English (en)
Inventor
Calvin John Ross
Original Assignee
Londonpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0906971.7A external-priority patent/GB2469791B/en
Priority claimed from PCT/GB2009/050415 external-priority patent/WO2010122275A1/en
Application filed by Londonpharma Ltd filed Critical Londonpharma Ltd
Application granted granted Critical
Publication of DK2424523T3 publication Critical patent/DK2424523T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK10715337.1T 2009-04-23 2010-04-23 Sublingual sprayformulering med dihydroartemisinin DK2424523T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0906971.7A GB2469791B (en) 2009-04-23 2009-04-23 Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
PCT/GB2009/050415 WO2010122275A1 (en) 2009-04-23 2009-04-23 Pharmaceutical preparation
PCT/GB2010/050672 WO2010122356A1 (en) 2009-04-23 2010-04-23 Sublingual spray formulation comprising dihydroartemesinin

Publications (1)

Publication Number Publication Date
DK2424523T3 true DK2424523T3 (da) 2012-09-24

Family

ID=42244197

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10715337.1T DK2424523T3 (da) 2009-04-23 2010-04-23 Sublingual sprayformulering med dihydroartemisinin

Country Status (24)

Country Link
US (4) US20120157518A1 (da)
EP (1) EP2424523B1 (da)
JP (1) JP5795760B2 (da)
CN (1) CN102395362B (da)
AU (1) AU2010240654C1 (da)
BR (1) BRPI1014887A8 (da)
CA (1) CA2756925A1 (da)
DK (1) DK2424523T3 (da)
ES (1) ES2390046T3 (da)
HK (1) HK1164140A1 (da)
HR (1) HRP20120711T1 (da)
IL (1) IL215453A (da)
ME (1) ME02008B (da)
MX (1) MX2011010961A (da)
MY (1) MY155646A (da)
NZ (1) NZ595469A (da)
PL (1) PL2424523T3 (da)
PT (1) PT2424523E (da)
RS (1) RS52430B (da)
RU (1) RU2501550C2 (da)
SG (1) SG175162A1 (da)
SI (1) SI2424523T1 (da)
WO (1) WO2010122356A1 (da)
ZA (1) ZA201107088B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
CA2756879A1 (en) * 2009-04-23 2010-10-28 Londonpharma Ltd. Sublingual pharmaceutical composition comprising a neutral oil
JP6513576B2 (ja) * 2013-01-14 2019-05-15 ヘルス クリニックス リミテッド 抗がん剤および使用
WO2016083827A1 (en) 2014-11-27 2016-06-02 Cipla Limited Pharmaceutical composition comprising an artemisinin derivative for nasal or pulmonary delivery
JP2020033304A (ja) * 2018-08-30 2020-03-05 医療法人ふじいやさか 薬剤又はサプリメント、組成物、及び水素供給器の使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
CA2337119A1 (en) * 1998-07-14 2000-01-27 Richard K. Haynes Antiparasitic artemisinin derivatives (endoperoxides)
WO2002053138A2 (en) * 2001-01-02 2002-07-11 Elisabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
AU2003240824B9 (en) * 2002-05-31 2008-09-25 University Of Mississippi Transmucosal delivery of cannabinoids
AU2003243418B2 (en) * 2002-06-06 2009-02-19 University Of Washington Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
WO2004075921A1 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Inclusion complex of artemisinin or derivates thereof with cyclodextrins
US20060084675A1 (en) * 2004-10-18 2006-04-20 Thomas Efferth Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor
US20060233895A1 (en) * 2005-04-15 2006-10-19 Brown Paul R Herbal remedy for treating Lyme disease
PT1933809E (pt) * 2005-10-11 2012-04-26 Yissum Res Dev Co Composições para administração por via nasal
CN100418524C (zh) * 2005-10-26 2008-09-17 重庆医药工业研究院有限责任公司 一种稳定的青蒿素及青蒿素衍生物的药物组合物

Also Published As

Publication number Publication date
CN102395362A (zh) 2012-03-28
US20170368023A1 (en) 2017-12-28
ZA201107088B (en) 2012-12-27
IL215453A (en) 2014-11-30
AU2010240654B2 (en) 2014-05-08
ES2390046T3 (es) 2012-11-06
IL215453A0 (en) 2011-12-29
US20190142737A1 (en) 2019-05-16
SG175162A1 (en) 2011-11-28
CN102395362B (zh) 2014-07-02
RU2501550C2 (ru) 2013-12-20
PT2424523E (pt) 2012-10-03
PL2424523T3 (pl) 2012-11-30
MY155646A (en) 2015-11-13
US20120157518A1 (en) 2012-06-21
HRP20120711T1 (hr) 2012-10-31
BRPI1014887A2 (pt) 2016-04-19
BRPI1014887A8 (pt) 2019-02-12
AU2010240654A1 (en) 2011-10-20
JP2012524772A (ja) 2012-10-18
US20160022629A1 (en) 2016-01-28
WO2010122356A1 (en) 2010-10-28
EP2424523B1 (en) 2012-06-27
JP5795760B2 (ja) 2015-10-14
AU2010240654C1 (en) 2014-08-14
RU2011139637A (ru) 2013-05-27
ME02008B (me) 2013-02-28
HK1164140A1 (en) 2012-09-21
EP2424523A1 (en) 2012-03-07
MX2011010961A (es) 2012-04-20
CA2756925A1 (en) 2010-10-28
RS52430B (en) 2013-02-28
NZ595469A (en) 2013-10-25
SI2424523T1 (sl) 2012-11-30

Similar Documents

Publication Publication Date Title
BRPI0908116A2 (pt) pulverizador
BRPI1009465A2 (pt) Formulação
DK2308607T3 (da) Belægningsstruktur
ATE546999T1 (de) Feldspritze
BRPI0924747A2 (pt) bocal de reparo
FI20086158A0 (fi) Imidatsopyridiinijohdannaiset
DK2380892T3 (da) Imidazothiazolderivat med prolinringstruktur
BRPI1004347A2 (pt) bocal de imersão
DE112010004815A5 (de) Verstellbare düse
DK2424523T3 (da) Sublingual sprayformulering med dihydroartemisinin
DK2221271T3 (da) Arbejdsplatform
FI8653U1 (fi) Suutin
FI20095741A0 (fi) Suihkutuspää
FI20095951A0 (fi) Kaasusumutinkotelo
DK2386008T3 (da) Gelænderkonstruktion
FIU20100519U0 (fi) Kaiderakenne
IT1396677B1 (it) Gioco
IT1393273B1 (it) Ringhiera per strutture fisse
UA19575S (uk) Обприскувач
TH106983B (th) อนุพันธ์ของซับสทิทิวเทด พิริมิโด ไอโซควิโนลีน
FI8447U1 (fi) Kaidejärjestely
UA19560S (uk) Насадка
DK2246118T3 (da) Strålerør
ES1071132Y (es) Boquilla mejorada
FR2951209B1 (fr) Escalier